Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
New vendor-agnostic interoperability advancements in Oracle Randomization and Trial Supply Management enable drug pooling and seamless supply management automation across multiple trials AUSTIN, Texas , June 4, 2025 /PRNewswire/ -- New interoperability advancements in Oracle's enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product.
The latest trading day saw Oracle (ORCL) settling at $169.14, representing a +1.54% change from its previous close.
![]() ORCL In 1 month Estimated | Quarterly | $0.5 Per Share |
![]() ORCL 1 month ago Paid | Quarterly | $0.5 Per Share |
![]() ORCL 4 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 7 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 10 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 9 Apr 2024 Paid | Quarterly | $0.4 Per Share |
11 Jun 2025 (6 Days) Date | | - Cons. EPS | - EPS |
9 Jun 2025 (4 Days) Date | | - Cons. EPS | - EPS |
10 Mar 2025 Date | | 1.49 Cons. EPS | 1.47 EPS |
9 Dec 2024 Date | | 1.48 Cons. EPS | 1.47 EPS |
9 Sep 2024 Date | | 1.33 Cons. EPS | 1.39 EPS |
![]() ORCL In 1 month Estimated | Quarterly | $0.5 Per Share |
![]() ORCL 1 month ago Paid | Quarterly | $0.5 Per Share |
![]() ORCL 4 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 7 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 10 months ago Paid | Quarterly | $0.4 Per Share |
![]() ORCL 9 Apr 2024 Paid | Quarterly | $0.4 Per Share |
11 Jun 2025 (6 Days) Date | | - Cons. EPS | - EPS |
9 Jun 2025 (4 Days) Date | | - Cons. EPS | - EPS |
10 Mar 2025 Date | | 1.49 Cons. EPS | 1.47 EPS |
9 Dec 2024 Date | | 1.48 Cons. EPS | 1.47 EPS |
9 Sep 2024 Date | | 1.33 Cons. EPS | 1.39 EPS |
Software - Infrastructure Industry | Technology Sector | Ms. Safra Ada Catz CEO | XWBO Exchange | US68389X1054 ISIN |
US Country | 159,000 Employees | 10 Apr 2025 Last Dividend | 13 Oct 2000 Last Split | 12 Mar 1986 IPO Date |
Oracle Corporation is a global provider of enterprise information technology solutions. The company delivers a wide range of products and services designed to meet the complex demands of modern IT environments. With a broad portfolio that includes everything from cloud software applications and infrastructure technologies to hardware products, Oracle aims to support businesses across various industries, government agencies, and educational institutions. The company's collaborative efforts, like its partnership with Amdocs Limited, highlight its commitment to facilitating cloud and digital adoption for its customers. Founded in 1977, Oracle has established its headquarters in Austin, Texas, marking its significance in the tech industry for several decades.
Oracle Corporation's extensive array of products and services caters to a diverse range of enterprise IT needs:
In its effort to meet the demands of businesses, government agencies, and educational institutions, Oracle employs direct and indirect sales channels, further expanding its reach and influence in the IT sector.